Large-scale testing (Phase 3)UnknownNCT02738619What this trial is testingAllergic Rhinitis, Immunotherapy and Vitamin dWho this might be right forAllergy Hospital General de Mexico 60
Early research (Phase 1)Ended earlyNCT01143545What this trial is testingPilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasWho this might be right forLung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830355What this trial is testingImmunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph NodesWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 75
Testing effectiveness (Phase 2)Study completedNCT00323115What this trial is testingPhase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme Dartmouth-Hitchcock Medical Center 11
Early research (Phase 1)Study completedNCT00112242What this trial is testingImmunotherapy of Stage III/IV Melanoma PatientsWho this might be right forMelanoma Centre Hospitalier Universitaire Vaudois 39
Post-approval studies (Phase 4)Not Yet RecruitingNCT07161453What this trial is testingComparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative PathologyWho this might be right forGastric / Gastroesophageal Junction Adenocarcinoma Liaoning Cancer Hospital & Institute 500
Large-scale testing (Phase 3)Active Not RecruitingNCT05751928What this trial is testingNeoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin MelanomaWho this might be right forMelanoma Stage IIIMelanoma (Skin) Biocad 411
Large-scale testing (Phase 3)Looking for participantsNCT07554846What this trial is testingComparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCWho this might be right forResectable Stage II-IIIa NSCLC Fudan University 759
Large-scale testing (Phase 3)Active Not RecruitingNCT03732677What this trial is testingDurvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBCWho this might be right forMuscle Invasive Bladder Cancer AstraZeneca 1,063
Testing effectiveness (Phase 2)WithdrawnNCT04267237What this trial is testingThe Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) Hoffmann-La Roche
Early research (Phase 1)Looking for participantsNCT06586255What this trial is testingAdjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder CancerWho this might be right forUrothelial Carcinoma BladderBladder Cancer Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)WithdrawnNCT03768531What this trial is testingSafety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract CancerWho this might be right forResectable Biliary Tract Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableLooking for participantsNCT06599619What this trial is testingEffects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviWho this might be right forMelanoma John Kirkwood 30
Not applicableUnknownNCT05062096What this trial is testingCharacterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of RecurrenceWho this might be right forMelanoma Assistance Publique - Hôpitaux de Paris 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT05468138What this trial is testingPD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical SurgeryWho this might be right forMSI-HPD-1 ImmunotherapyGastric Cancer+1 more Fudan University 94
Testing effectiveness (Phase 2)Looking for participantsNCT03406247What this trial is testingAdjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Gustave Roussy, Cancer Campus, Grand Paris 140
Testing effectiveness (Phase 2)Study completedNCT01595321What this trial is testingPancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the PancreasWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT01094496What this trial is testingThe CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)Who this might be right forBladder Cancer Celldex Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT03081689What this trial is testingNeo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer PatientsWho this might be right forNon Small Cell Lung Cancer Spanish Lung Cancer Group 46
Testing effectiveness (Phase 2)Ended earlyNCT04455503What this trial is testingStudy of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1Who this might be right forMelanoma Stage IVMelanoma Stage III Evaxion Biotech A/S 15